del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma
del(17p) 且无 TP53 突变预示着接受强化治疗的新诊断多发性骨髓瘤患者预后不良。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020008346
Corre, Jill; Perrot, Aurore; Caillot, Denis; Belhadj, Karim; Hulin, Cyrille; Leleu, Xavier; Mohty, Mohamad; Facon, Thierry; Buisson, Laure; Do Souto, Laura; Lannes, Romain; Dufrechou, Stephanie; Prade, Naïs; Orsini-Piocelle, Frederique; Voillat, Laurent; Jaccard, Arnaud; Karlin, Lionel; Macro, Margaret; Brechignac, Sabine; Dib, Mamoun; Sanhes, Laurence; Fontan, Jean; Clement-Filliatre, Lauriane; Marolleau, Jean-Pierre; Minvielle, Stephane; Moreau, Philippe; Avet-Loiseau, Hervé